Skip to content
Inciteful Med

Symptoms and Early Warning Signs of AGS

Last updated:

Aicardi-Goutières syndrome (AGS) is a rare genetic disorder causing severe brain inflammation. Early symptoms usually appear in a child's first year during an encephalopathic phase, marked by extreme irritability, unexplained fevers, loss of milestones, and skin sores called chilblains.

Key Takeaways

  • • AGS typically presents with an initial stormy encephalopathic phase in the first year of life, featuring extreme irritability, unexplained fevers, and milestone loss.
  • • Neurological symptoms vary widely but often include spasticity, dystonia, acquired microcephaly, and seizures.
  • • Chilblains, which are painful red or purple sores on the fingers, toes, or ears, are a hallmark physical sign of the immune system overreacting in AGS.
  • • Because it causes stiffness and developmental delays, AGS is frequently misdiagnosed as cerebral palsy before genetic testing is performed.
  • • After the active inflammatory phase, the disease typically reaches a stable phase where the medical focus shifts to developmental support and symptom management.

Aicardi-Goutières syndrome (AGS) is a multisystem disorder, meaning it affects both the brain (neurological) and the rest of the body (systemic) [1]. While the most significant challenges often involve the brain, the “early warning signs” can appear in many different ways. Understanding these symptoms can help you and your medical team provide the best support for your child [2][3].

The Encephalopathic Phase

Many children with AGS go through an initial “stormy” period called the encephalopathic phase [3]. This typically happens in the first year of life [4]. During this time, the brain is under intense inflammation. You might notice:

  • Extreme Irritability: Inconsolable crying and difficulty sleeping [3].
  • Unexplained Fevers: High temperatures without any sign of a real infection (sometimes called “sterile pyrexia”) [3][5].
  • Loss of Milestones: A child who was sitting or rolling may suddenly stop doing so [4].

Neurological Symptoms

As the disease progresses, the primary impact is on the nervous system. The severity varies widely from child to child [6][5].

  • Spasticity and Dystonia: Spasticity refers to tight, stiff muscles, while dystonia involves involuntary muscle contractions that cause twisting or repetitive movements [5][7].
  • Acquired Microcephaly: This means the head does not grow as quickly as the rest of the body because the brain is not growing at a typical rate [5][6].
  • Seizures: Many children with AGS will experience seizures at some point, which require medical management [6].
  • Developmental Delay: Most children will have significant challenges with motor skills and communication [5].

Systemic (Body-Wide) Symptoms

AGS is more than a brain disorder; it is a whole-body inflammatory condition [1].

  • Chilblains: These are painful, itchy, red or purple sores that usually appear on the fingers, toes, or ears [8][9]. They are often triggered or worsened by cold weather and are a hallmark sign of the immune system overreacting [9][10]. Tip: Keeping extremities warm with gloves and thick socks, and avoiding cold exposure, can be a practical way to manage and prevent these sores.
  • Liver and Spleen Issues: Some children have an enlarged liver or spleen (hepatosplenomegaly) or elevated liver enzymes [11][12].
  • Hormonal Changes: Over time, the inflammation can affect the thyroid or other glands, leading to conditions like hypothyroidism [13][11].
  • Blood Count Changes: Some children may have low levels of platelets (thrombocytopenia) or white blood cells [11][14].

Daily Living and Feeding Challenges

The severe brain inflammation often impacts daily living, particularly the muscles used for eating and breathing [15][16].

  • Feeding and Swallowing Issues: Many children with AGS develop difficulties with safe swallowing, leading to a risk of aspiration (food or liquid entering the lungs) [5].
  • G-Tubes: Because of these swallowing issues and the high energy needed to fight inflammation, many children require feeding tubes (gastrostomy tubes or G-tubes) to ensure they receive adequate nutrition safely [15].
  • Respiratory Support: Children may also have weakened respiratory muscles and need breathing support or airway clearance techniques, especially when they catch a cold [15].

Conditions Often Confused with AGS

Because AGS is rare, it is frequently misidentified as other conditions before a genetic test confirms the diagnosis [12][17].

  • Cerebral Palsy (CP): Because AGS causes stiffness and motor delay, many children are initially diagnosed with CP [18][19].
  • Congenital Infections: As discussed, the brain scans can look exactly like a child who was born with a virus like CMV [12][17].
  • Other Leukodystrophies: Other rare genetic brain disorders can share similar features, though the presence of chilblains and high interferon levels are unique to AGS [20][21].

How Symptoms Progress

While the early phase can be very intense, for many children, the disease eventually reaches a “stable” or chronic phase [18][15]. During this time, the active inflammation slows down, and the focus shifts from managing the “storm” to supporting the child’s development and comfort [22][15]. Even in the stable phase, regular screening for things like thyroid function is important [13].

Frequently Asked Questions

What is the encephalopathic phase of AGS?
The encephalopathic phase is an initial stormy period, usually occurring in the first year of life, where the brain undergoes intense inflammation. During this time, children may experience extreme irritability, unexplained fevers, and a sudden loss of developmental milestones like rolling or sitting.
What do chilblains look like in children with AGS?
Chilblains are painful, itchy, red or purple sores that typically appear on a child's fingers, toes, or ears. They are a hallmark physical sign of the immune system overreacting in AGS and can be triggered or worsened by cold weather.
How does Aicardi-Goutières syndrome affect swallowing and feeding?
Severe brain inflammation in AGS can weaken the muscles used for eating and breathing, making it difficult to swallow safely. Because of this, many children require a feeding tube (G-tube) to prevent food from entering the lungs and to ensure they get enough nutrition.
Will the symptoms of AGS continue to get worse over time?
While the early encephalopathic phase involves intense active inflammation, the disease often eventually reaches a stable or chronic phase. During this time, the active inflammation slows down, and the medical focus shifts toward supporting the child's ongoing development and comfort.
What conditions are often confused with Aicardi-Goutières syndrome?
Because AGS is rare and causes stiffness and motor delays, it is frequently misdiagnosed initially as cerebral palsy. It can also be confused with congenital viral infections or other rare genetic brain disorders before a genetic test confirms the true diagnosis.

Questions for Your Doctor

  • • Has our child entered the 'stable phase' of the disease, or are they still in the 'encephalopathic phase'?
  • • Can you explain the results of our child's 'interferon signature' test and how it relates to their current symptoms?
  • • Should we be screening for thyroid or liver issues even if our child doesn't show obvious symptoms of them yet?
  • • Is the current stiffness we see in our child's limbs considered 'dystonia' or 'spasticity,' and what is the best way to manage it?
  • • Given our child's specific gene mutation, are they at higher risk for certain systemic issues like moyamoya or kidney problems?

Questions for You

  • • Have you noticed your child becoming unusually irritable or having periods of unexplained fever?
  • • Do you see any red or purple sores on your child's fingers, toes, or ears, especially when the weather gets colder?
  • • Has your child lost any skills they previously had, such as the ability to roll over, sit up, or make eye contact?
  • • Are you observing any signs of difficulty swallowing or feeding?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    New Phenotypes Associated With Pathogenic RNASEH2B and SAMHD1 Variants.

    Abdel-Salam GMH, Eid M, El-Serafy MA, et al.

    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2025; (85(3)):e70019 doi:10.1002/jdn.70019.

    PMID: 40302656
  2. 2

    Diagnosis of Aicardi-Goutières Syndrome in Adults: A Case Series.

    Videira G, Malaquias MJ, Laranjinha I, et al.

    Movement disorders clinical practice 2020; (7(3)):303-307 doi:10.1002/mdc3.12903.

    PMID: 32258229
  3. 3

    Systemic complications of Aicardi Goutières syndrome using real-world data.

    Peixoto de Barcelos I, Jan AK, Modesti N, et al.

    Molecular genetics and metabolism 2024; (143(1-2)):108578 doi:10.1016/j.ymgme.2024.108578.

    PMID: 39332260
  4. 4

    [Aicardi-Goutieres syndrome: a family case due to alteration of the RNASEH2B gene].

    Viguera-Elías D, de la Iglesia-Nagore I, Toledo-Gotor C, et al.

    Revista de neurologia 2021; (72(11)):407-409 doi:10.33588/rn.7211.2021071.

    PMID: 34042169
  5. 5

    Developmental Outcomes of Aicardi Goutières Syndrome.

    Adang L, Gavazzi F, De Simone M, et al.

    Journal of child neurology 2020; (35(1)):7-16 doi:10.1177/0883073819870944.

    PMID: 31559893
  6. 6

    Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients.

    Al Mutairi F, Alfadhel M, Nashabat M, et al.

    Pediatric neurology 2018; (78()):35-40 doi:10.1016/j.pediatrneurol.2017.09.002.

    PMID: 29239743
  7. 7

    Delayed Diagnosis of Aicardi-Goutières Syndrome in a 10-Year-Old Female Child With TREX1 Mutation: A Case Report.

    Al Zayer L, Al Zayer M, Alrujaib A, et al.

    Cureus 2025; (17(2)):e79730 doi:10.7759/cureus.79730.

    PMID: 40161088
  8. 8

    Exploring emerging JAK inhibitors in the treatment of Aicardi-Goutières syndrome.

    Politano D, Tonduti D, Battini R, et al.

    Expert opinion on emerging drugs 2024; 1-19 doi:10.1080/14728214.2024.2445508.

    PMID: 39704072
  9. 9

    Systematic analysis of genotype-phenotype variability in siblings with Aicardi Goutières Syndrome (AGS).

    de Barcelos IP, Woidill S, Gavazzi F, et al.

    Molecular genetics and metabolism 2024; (142(1)):108346 doi:10.1016/j.ymgme.2024.108346.

    PMID: 38368708
  10. 10

    An Evidence-Based Review of Perniosis (Chilblains): Therapeutic Strategies and Integration With Raynaud's Syndrome Management.

    Sharifzadeh A, Smith GP

    International journal of dermatology 2025; (64(10)):1781-1787 doi:10.1111/ijd.17812.

    PMID: 40272049
  11. 11

    Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China.

    Wang W, Wang W, He TY, et al.

    World journal of pediatrics : WJP 2022; (18(7)):490-497 doi:10.1007/s12519-022-00545-1.

    PMID: 35551623
  12. 12

    Aicardi-Goutières syndrome (AGS): recurrent fetal cardiomyopathy and pseudo-TORCH syndrome.

    Panigrahy N, Bakhru S, Lingappa L, Chirla D

    BMJ case reports 2022; (15(12)) doi:10.1136/bcr-2022-249192.

    PMID: 36581356
  13. 13

    Endocrinopathies in Aicardi Goutières syndrome-A descriptive case series.

    Worth C, Briggs TA, Padidela R, et al.

    Clinical case reports 2020; (8(11)):2181-2185 doi:10.1002/ccr3.3081.

    PMID: 33235754
  14. 14

    Phenotypic variability of a TREX1 variant in Aicardi-Goutieres type 1 patients from the Indian subcontinent.

    Abraham SSC, Yoganathan S, Koshy B, et al.

    European journal of medical genetics 2021; (64(9)):104291 doi:10.1016/j.ejmg.2021.104291.

    PMID: 34303877
  15. 15

    Experiences and Hope in Caregivers of Children With Aicardi Goutières Syndrome.

    Gavazzi F, Martin A, Sevagamoorthy A, et al.

    Journal of child neurology 2025; (40(7)):543-554 doi:10.1177/08830738251341530.

    PMID: 40400365
  16. 16

    Neuropathologic Impacts of JAK Inhibitor Treatment in Aicardi-Goutières Syndrome.

    Jafarpour S, Suddock J, Hawes D, Santoro JD

    Journal of clinical immunology 2024; (44(3)):68 doi:10.1007/s10875-024-01672-2.

    PMID: 38381212
  17. 17

    Clinical and neuroradiologic variability of Aicardi-Goutiéres syndrome: Two siblings with RNASEH2C mutation and a boy with TREX1 mutation.

    Uyur Yalçın E, Maraş Genç H, Kara B

    The Turkish journal of pediatrics 2015; (57(5)):504-8.

    PMID: 27411419
  18. 18

    Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?

    Svingen L, Goheen M, Godfrey R, et al.

    Developmental medicine and child neurology 2017; (59(12)):1307-1311 doi:10.1111/dmcn.13509.

    PMID: 28762473
  19. 19

    Autosomal dominant ADAR c.3019G>A (p.(G1007R)) variant is an important mimic of hereditary spastic paraplegia and cerebral palsy.

    Jones HF, Stoll M, Ho G, et al.

    Brain & development 2022; (44(2)):153-160 doi:10.1016/j.braindev.2021.10.001.

    PMID: 34702576
  20. 20

    Clinical, radiological and possible pathological overlap of cystic leukoencephalopathy without megalencephaly and Aicardi-Goutières syndrome.

    Tonduti D, Orcesi S, Jenkinson EM, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(4)):604-10.

    PMID: 27091087
  21. 21

    Childhood-inherited white matter disorders with calcification.

    Livingston JH

    Handbook of clinical neurology 2024; (204()):95-109 doi:10.1016/B978-0-323-99209-1.00013-2.

    PMID: 39322397
  22. 22

    Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome.

    Galli J, Cattalini M, Loi E, et al.

    Clinical case reports 2023; (11(8)):e7724 doi:10.1002/ccr3.7724.

    PMID: 37534202

This page explains the symptoms and progression of Aicardi-Goutières syndrome for educational purposes. Always consult your child's pediatric neurologist or healthcare team for medical advice and symptom management.

Stay up to date

Get notified when new research about Aicardi-Goutières syndrome is published.

No spam. Unsubscribe anytime.